Genomic Testing Cooperative

Genomic Testing Cooperative State-of-the-art Innovation
Machine/deep Learning meets Next Generation Sequencing

When patients present with neurologic symptoms suggestive of leptomeningeal disease (LMD), timely and accurate molecular...
02/26/2026

When patients present with neurologic symptoms suggestive of leptomeningeal disease (LMD), timely and accurate molecular insight can be critical. Traditional diagnostics—CSF cytology, imaging, and plasma-based testing—often lack sensitivity in this setting.

Liquid Trace® on CSF is designed to address these gaps:
· Higher tumor signal than plasma for CNS-confined disease due to the blood–brain barrier
· Improved detection when cytology is negative or equivocal
· Comprehensive genomic profiling from limited CSF input, supporting therapy selection
· Actionable insights for metastatic and primary CNS malignancies using a single assay
· Clinically practical when tissue is unavailable or unsafe to obtain

Liquid Trace™ On Cerebral Spinal Fluid (CSF) | Genomic Testing Cooperative

Limited tissue should not limit clinical insight. GTC is optimized to deliver comprehensive solid tumor profiling from v...
02/25/2026

Limited tissue should not limit clinical insight. GTC is optimized to deliver comprehensive solid tumor profiling from very small quantities of tissue, including scant samples with as little as 6-8 slides.

Our advanced NGS workflows are designed to maximize yield from low-input specimens, enabling:

Parallel DNA and RNA sequencing from minimal tissue

Detection of mutations, copy number changes, and gene fusions

Gene expression and immune profiling to support therapy selection

Preservation of tissues for future testing or clinical needs

https://genomictestingcooperative.com/genomic-tests/solid-tumor-profile-plus/

About our new team member:Anamaria Munteanu is a board certified pathologist with experience in clinical and academic se...
02/24/2026

About our new team member:
Anamaria Munteanu is a board certified pathologist with experience in clinical and academic setting. She completed her AP/CP residency at UCLA-Harbor, Molecular Genetic Pathology fellowship at University of California Los Angeles (UCLA), and Hematopathology fellowship at City of Hope, in Los Angeles. Previously, she obtained her PhD at University of Southern California followed by postdoctoral studies investigating the role of somatic mutations in the pathobiology of breast adenocarcinoma. Her scientific interests lie in studying innovative applications of genetic profiling tools leading to accurate diagnosis and personalized treatment in cancer patients.

We’re excited to share that our CEO & CMO, Dr. Maher Albitar, will be speaking at Best of SABCS – New Jersey on February...
02/23/2026

We’re excited to share that our CEO & CMO, Dr. Maher Albitar, will be speaking at Best of SABCS – New Jersey on February 27.

Talk title: The Role of CSF Liquid Biopsy in Evaluating and Monitoring CNS Involvement in Breast Cancer

Join us for insights into how CSF-based liquid biopsy is advancing CNS disease assessment and monitoring.

GTC offers an expanded suite of IHC markers as an add on to any of our solid tumor tissue tests. These CDx assays help r...
02/18/2026

GTC offers an expanded suite of IHC markers as an add on to any of our solid tumor tissue tests. These CDx assays help refine patient selection for targeted therapies and strengthen clinical decision-making with clearer, more actionable insights.

Learn more: https://genomictestingcooperative.com/ihc-testing/

Stop by and visit GTC in Redondo Beach Feb 27-28 and discuss your testing needs for hematologic malignancies.
02/17/2026

Stop by and visit GTC in Redondo Beach Feb 27-28 and discuss your testing needs for hematologic malignancies.

It's National Donor Day—a time to recognize the lifesaving impact of organ, tissue, blood, platelet, and marrow donors.D...
02/14/2026

It's National Donor Day—a time to recognize the lifesaving impact of organ, tissue, blood, platelet, and marrow donors.

Donors give patients a second chance—supporting life-saving transplants, advancing medical research, and ensuring hospitals have the resources needed for critical care. One donor can impact dozens of lives, and every contribution matters.

GTC delivers a comprehensive approach to lymphoma testing that goes beyond routine pathology:• DNA and RNA analysis with...
02/13/2026

GTC delivers a comprehensive approach to lymphoma testing that goes beyond routine pathology:

• DNA and RNA analysis with Hematology Profile Plus and Liquid Trace®
•Precise lymphoma subtyping, including cell of origin
•Detection of actionable mutations, fusions, clonality, and EBV
•Liquid biopsy provides insight into tumor heterogeneity, transformation and therapeutic monitoring
•Reliable results even when tissue is limited – only 6-8 slides required
•Turnaround time of 5–10 days for faster treatment decisions

Get the molecular clarity and a precise classification needed for confident diagnosis, prognosis, and therapy selection.

Address

25371 Commercentre Drive
Lake Forest, CA
92630

Telephone

+19495409421

Website

Alerts

Be the first to know and let us send you an email when Genomic Testing Cooperative posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Genomic Testing Cooperative:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category